Published On: Thu, Dec 5th, 2013

Mix Stock in Focus: G-III Apparel Group (GIII), Sears Holdings Corp (SHLD), Celldex Therapeutics (CLDX)

G-III Apparel Group, Ltd. (NASDAQ:GIII), stock in last trading session surged 13.31% as it declared that apparel’s fiscal Q3 earnings surged 23%, exceeding expectations, as the firm recorded strong sales across all segments and brands. The firm raised its per-share earnings anticipates for the year.

ON THE OTHER FRONT: The analysts’ average revenue estimates for the firm is $ 629.28M in fourth quarter of 2013 and 3 experts  predict 483.75M revenue for the first quarter of 2014. Currently, 1 analyst that rates G-III Apparel Group at “Hold,” 4 analyst rate it at “Buy” and 4 rate it as “Strongly Buy.”

Shares of Sears Holdings Corp (NASDAQ:SHLD) after opening at $52.62 reached its day high price of $ 52.65 and then closed at $50.92 by shares moved down -8.33% in last trading session. As the investors who made a verdict to egress from Edward Lampert’s hedge fund this year got payment in Sears stock. The fund, ESL Partners, released that it dispersed about 7.4M shares of Sears Holdings Corp. to those investors. The stock was valued at around $445M at the closing price Monday, the date on a securities filing disclosing the move.

AVERAGE ANTICIPATION: For fourth quarter of 2013, the consensus average estimate of street for the revenue is 11.09B, while 1 analyst predicts 8.08B revenue for the first quarter of 2014. For current quarter, firm sales growth (year/est) is forecasted -9.50% and for first quarter 2014 was predicted -4.40%.

Shares of Celldex Therapeutics, Inc.(NASDAQ:CLDX) stocks slumped -3.61% in last trading session as it has a market cap of $ 2.12B  with outstanding shares of 80.90M. It declared outlined plans to propose 6.5M shares. The company, which develops therapeutics to address diseases for which available treatments are inadequate, has around 81M shares outstanding.

CURRENT ANALYSTS RATING: In last month recommendation trend, 2 analysts that rate its stock at “buy,” no analyst’s rate it a sell security. While the mean recommendation of this week is 1.2, {(Strong Buy) 1.0 – 5.0 (Sell)} as compare to last week recommendation of 1.2, which denotes zero change in recommendations.


This content does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the company’s stocks or securities. As well nor shall there be any sale of the company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be illegal prior to registration or qualification under the securities laws of any such state or jurisdiction. only provide news and information about stocks with intentions that it may be helpful  for investor to take investment decision on their own risk. It is “RECOMMENDED” at all times do your own due diligence; along with consult your financial advisor.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>